Emergency use of drugs authorised for COVID-19

US to allow hydroxychloroquine and chloroquine from national stockpile to be distributed and used for certain hospitalised patients infected with COVID-19 The Food and Drug Administration (FDA) in the United States has decided that the benefits of using hydroxychloroquine and chloroquine to treat COVID-19 patients outweigh the risks, despite clinical trials having not yet been

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous SA joins extended emergency supply
Next PHNs need to ‘pull their socks up,’ says Twomey